NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-227-2006-5-EP-08 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS EP DIV 13180563.2 Issued
NCI E-227-2006-5-FR-18 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS FR EP 13180563.2 Issued
NCI E-227-2006-5-DE-17 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS DE EP 13180563.2 Issued
NCI E-227-2006-5-GB-19 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS GB EP 13180563.2 Issued
NCI E-227-2006-5-EP-05 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS EP National Stage 07868382.8 Issued
NCI E-227-2006-5-AU-04 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS AU National Stage 2007319576 Issued
NIDDK E-063-2007-1-PCT-02 EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE PCT PCT PCT/US2007/021409 Expired
NCI E-227-2006-5-PCT-01 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS PCT PCT COMB PCT/US2007/080647 Expired
NIDDK E-063-2007-1-EP-07 EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE EP National Stage 7852549 Abandoned
NIDDK E-063-2007-1-AU-05 EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE AU National Stage 2007307157 Abandoned
NCI E-227-2006-5-CA-22 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS CA DIV 3163418 Pending
NIDDK E-063-2007-1-CA-06 EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE CA National Stage 2665616 Abandoned
NIDDK E-063-2007-1-IN-04 Delivery Of Cross Species A3 Adenosine-receptor Antagonist To Reduce Intracoular Pressure IN National Stage 2479/CHENP/2009 Pending
NIDDK E-198-2007-0-US-01 DETECTION OF KIDNEY INJURIES AND CONDITIONS US 60/977,827 Abandoned
NEI E-220-2001-0-US-47 Nutritional Supplement to Treat Macular Degeneration US REEXAM 95/000,301 6660297 Expired PDF
NCI E-281-2007-0-US-01 Stably Transfected Multicolored Fluorescent Cells US 60/976,732 Abandoned
NIAID E-092-2002-0-US-09 Recovery of Recombinant Human Parainfluenza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and other Human Pathogens US DIV 11/864,120 7919301 Expired PDF
NCI E-264-2006-0-PCT-02 Stilbenedisulfonic Acid Derivatives as Inhibitors of Retroviral Integrase PCT PCT PCT/US2007/79980 Abandoned
NINDS E-125-2004-0-US-03 Grid Etcher US DIV 11/864,765 Abandoned
NIAID E-092-2002-0-US-10 Recovery of Recombinant Human Parainfluenza Virus Type 2 (HPIV2) From cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens US DIV 11/863,196 8367074 Issued PDF
NCI E-004-2005-4-CH-11 Human Monoclonal Antibodies Against Hendra And Nipah CH EP 05858301.4 Issued
NCI E-004-2005-4-GB-15 Human Monoclonal Antibodies Against Hendra And Nipah GB EP 05858301.4 Issued
NCI E-004-2005-4-NL-17 Human Monoclonal Antibodies Against Hendra And Nipah NL EP 05858301.4 Issued
NCI E-004-2005-4-BE-10 Human Monoclonal Antibodies Against Hendra And Nipah BE EP 05858301.4 Issued
NCI E-004-2005-4-FR-14 Human Monoclonal Antibodies Against Hendra And Nipah FR EP 05858301.4 Issued
NCI E-004-2005-4-ES-13 Human Monoclonal Antibodies Against Hendra And Nipah ES EP 05858301.4 Issued
NCI E-004-2005-4-IT-16 Human Monoclonal Antibodies Against Hendra And Nipah IT EP 05858301.4 Issued
NCI E-004-2005-4-DK-12 Human Monoclonal Antibodies Against Hendra And Nipah DK EP 05858301.4 Issued
NIAMS E-309-2006-2-PCT-01 Cell-Nanofiber Composite and Cell-nanofiber Composite Amalgam Based Engineered Intervertebra Disc PCT PCT COMB PCT/US07/020974 Expired
NHGRI E-312-2006-0-PCT-02 Methods For Detecting And Treating Attention-Deficit/Hyperactivity Disorder PCT PCT PCT/US2007/079616 Expired
NCI E-286-2006-2-PCT-01 SCGB3A2 AS A GROWTH FACTOR AND ANTI-APOPTOTIC AGENT PCT PCT COMB PCT/US2007/079771 Expired
NINDS E-187-2007-0-US-01 Isoindoline Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses US 60/975,675 Abandoned
NCI E-304-2006-0-PCT-02 MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS PCT PCT PCT/US2007/079487 Expired
NHLBI E-145-2010-0-US-01 Methods And Compositions For Modulating BCL-2 Family Polypeptides US 60/995,545 Abandoned
NCI E-312-2007-0-US-01 MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS US 60/974,872 Abandoned
NCI E-313-2007-1-US-01 METHOD FOR OBTAINING THREE-DIMENSIONAL COMPOSITIONAL MAPS OF A BIOLOGICAL SAMPLE US 60/974,686 Abandoned
NCI E-298-2007-0-US-01 IMMUNOSTIMULATORY COMBINATIONS OF TLR LIGANDS AND METHODS OF USE US 60/995,212 Abandoned
NCI E-311-2006-1-PCT-01 Compositions And Methods For Chitosan Enhanced Immune Response PCT PCT COMB PCT/US2007/020540 Expired
NIDDK E-308-2006-2-PCT-01 SYNTHESIS OF TRANS-TERT-BUTYL-2-AMINOCYCLOPENTYLCARBAMATE PCT PCT COMB PCT/US2007/020466 Expired
NIDDK E-308-2006-2-US-02 Synthesis of Trans-Tert- Butyl-2-Aminocyclopentylcarbamate US National Stage 12/441,925 Abandoned
NCI E-311-2006-1-EP-02 Compositions And Methods For Chitosan Enhanced Immune Response EP National Stage 07838692.7 Abandoned
NHLBI E-028-2008-0-US-01 Methods Of Treatment For Hemolysis US 60/973,878 Abandoned
CC E-278-1999-0-US-05 Multiplex Hybridization System For Identification Of Pathogenic Mycobacterium And Method Of Use US DIV 11/857,363 Abandoned
NEI E-154-2007-0-US-01 Methods for Treatment of Degenerative Disease Associated with Apoptosis US 60/972,780 Abandoned
NCI E-004-2005-4-US-02 Human Monoclonal Antibodies Against Hendra And Hipah US National Stage 11/886,307 7988971 Issued PDF
NCI E-265-1999-2-PCT-02 INHIBITION OF CELL MOTILITY, ANGIOGENESIS, AND METASTASIS PCT PCT PCT/US2007/078494 Expired
NCI E-153-2009-0-DK-08 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE DK EP 07838099.5 Issued
NCI E-153-2009-0-NL-14 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE NL EP 07838099.5 Issued
NCI E-153-2009-0-GB-12 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE GB EP 07838099.5 Issued
NCI E-153-2009-0-CH-06 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE CH EP 07838099.5 Issued